United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market (2025-2031) | Value, Analysis, Size & Revenue, Companies, Forecast, Industry, Trends, Segmentation, Share, Competitive Landscape, Growth, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market - Industry Life Cycle

3.4 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market - Porter's Five Forces

3.5 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Service Type, 2021 & 2031F

3.6 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.7 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing focus on personalized medicine and targeted therapies in cancer treatment

4.2.2 Rising prevalence of cancer cases in the United Kingdom

4.2.3 Technological advancements in cancer immunotherapy research and development

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and approval processes for cancer immunotherapy drugs

4.3.2 High costs associated with cancer immunotherapy drug discovery and development

4.3.3 Limited availability of skilled workforce in cancer immunotherapy research

6.1 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Service Type, 2021- 2031F

6.1.3 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Target Identification and Validation, 2021- 2031F

6.1.4 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Lead Screening and Characterization, 2021- 2031F

6.1.5 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Cell-based Assays, 2021- 2031F

6.2 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Lung, 2021- 2031F

6.2.3 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Breast, 2021- 2031F

6.2.4 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Colorectal, 2021- 2031F

6.2.5 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Melanoma, 2021- 2031F

6.2.6 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Prostate, 2021- 2031F

6.2.7 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Head and Neck, 2021- 2031F

6.3 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F

6.3.3 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Immunomodulators, 2021- 2031F

6.3.4 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Cancer Vaccines and Oncolytic Viral Therapy, 2021- 2031F

7.1 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Export to Major Countries

7.2 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Imports from Major Countries

8.1 Number of new clinical trials initiated for cancer immunotherapy drug discovery in the UK

8.2 Percentage increase in research funding allocated to cancer immunotherapy in the UK

8.3 Number of partnerships and collaborations between UK-based research institutions and pharmaceutical companies in the field of cancer immunotherapy

9.1 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Service Type, 2021 & 2031F

9.2 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.3 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Drug Type, 2021 & 2031F

10.1 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Benchmarking, By Operating and Technical Parameters